Predictors of benefit following pulmonary rehabilitation for interstitial lung disease
Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitati...
Saved in:
Published in | Respiratory medicine Vol. 106; no. 3; pp. 429 - 435 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier Ltd
01.03.2012
Elsevier Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0954-6111 1532-3064 1532-3064 |
DOI | 10.1016/j.rmed.2011.11.014 |
Cover
Abstract | Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation.
Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion.
In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (
r = 0.49,
p = 0.01), less exercise-induced oxyhaemoglobin desaturation (
r
S = 0.43,
p = 0.04) and lower right ventricular systolic pressure (
r = −0.47,
p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%,
p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months.
Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF. |
---|---|
AbstractList | Summary Background Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Methods Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. Results In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity ( r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation ( rS = 0.43, p = 0.04) and lower right ventricular systolic pressure ( r = −0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Conclusions Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF. Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation.BACKGROUNDPulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation.Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion.METHODSForty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion.In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r(S) = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months.RESULTSIn IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r(S) = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months.Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF.CONCLUSIONSPatients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF. Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r S = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF. 30 references Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r S = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF. Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity ( r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation ( r S = 0.43, p = 0.04) and lower right ventricular systolic pressure ( r = −0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF. Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes between individuals. The aim of this study was to establish the impact of the aetiology and severity of ILD on response to pulmonary rehabilitation. Forty-four subjects with ILD, including 25 with idiopathic pulmonary fibrosis (IPF), underwent eight weeks of pulmonary rehabilitation. Relationships between disease aetiology, markers of disease severity and response to pulmonary rehabilitation were assessed after eight weeks and six months, regardless of program completion. In IPF, greater improvements in 6-minute walk distance (6MWD) immediately following pulmonary rehabilitation were associated with larger forced vital capacity (r = 0.49, p = 0.01), less exercise-induced oxyhaemoglobin desaturation (r(S) = 0.43, p = 0.04) and lower right ventricular systolic pressure (r = -0.47, p = 0.1). In participants with other ILDs there was no relationship between change in 6MWD and baseline variables. Less exercise-induced oxyhaemoglobin desaturation at baseline independently predicted a larger improvement in 6MWD at six month follow-up. Fewer participants with IPF had clinically important reductions in dyspnoea at six months compared to those with other ILDs (25% vs 56%, p = 0.04). More severe dyspnoea at baseline and diagnosis other than IPF predicted greater improvement in dyspnoea at six months. Patients with IPF attain greater and more sustained benefits from pulmonary rehabilitation when disease is mild, whereas those with other ILDs achieve benefits regardless of disease severity. Early referral to pulmonary rehabilitation should be considered in IPF. |
Author | Goh, Nicole Holland, Anne E. Glaspole, Ian McDonald, Christine F. Hill, Catherine J. |
Author_xml | – sequence: 1 givenname: Anne E. surname: Holland fullname: Holland, Anne E. email: a.holland@alfred.org.au organization: Physiotherapy, Alfred Health, VIC 3004, Australia – sequence: 2 givenname: Catherine J. surname: Hill fullname: Hill, Catherine J. organization: Institute for Breathing and Sleep, VIC 3084, Australia – sequence: 3 givenname: Ian surname: Glaspole fullname: Glaspole, Ian organization: Allergy, Immunology and Respiratory Medicine, Alfred Health, VIC 3004, Australia – sequence: 4 givenname: Nicole surname: Goh fullname: Goh, Nicole organization: Institute for Breathing and Sleep, VIC 3084, Australia – sequence: 5 givenname: Christine F. surname: McDonald fullname: McDonald, Christine F. organization: Institute for Breathing and Sleep, VIC 3084, Australia |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25572644$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22182340$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkluLFDEQhYOsuLOrf8AHaRDRlx6TdCfpXkSQxRssKHh5DZl0tWbMJGOSVvbfW83MsjDgKBTk5TtVqTrnjJyEGICQh4wuGWXy-XqZNjAsOWVsiUVZe4csmGh43VDZnpAF7UVbS8bYKTnLeU0p7duW3iOnnLOONy1dkK8fEwzOlphyFcdqBQFGV6oxeh9_u_Ct2k5-E4NJ11WC72blvCumuBgQSZULBVIurjjjKz8hPrgMJsN9cnc0PsOD_XtOvrx5_fnyXX314e37y1dXtZW9KDUXK2AryzvBRwpMqd5KwD8CkwDMNkPXdIp2HSglRwuNHGDgUlEj5GAlb5pz8nTXd5vizwly0RuXLXhvAsQp655J2aOAIvnsKMnmYwnOufoPlKu-E4rN6OMDdB2nFHBlpBrBGiUFR-rRnppW6JjeJrfBi-obGxB4sgdMtsaPyQTr8i0nhOKybZHrdpxNMecEo7Z7O0oyzuNMPSdDr_WcDD0nQ2NhMlDKD6Q33Y-KXuxEgB7-cpB0tg6CxcgksEUP0R2XvzyQW--Cww1_wDXk21PpzDXVn2YL5rgyRmnbCIENLv7e4F_T_wDbI_g0 |
CitedBy_id | crossref_primary_10_1513_AnnalsATS_202306_561OC crossref_primary_10_1016_j_rmr_2017_07_017 crossref_primary_10_1016_j_rmr_2017_07_018 crossref_primary_10_1016_j_arbres_2013_03_011 crossref_primary_10_1080_17476348_2018_1472580 crossref_primary_10_1097_MCP_0b013e328363f4cb crossref_primary_10_1183_16000617_0220_2021 crossref_primary_10_1590_S1806_37132013000300012 crossref_primary_10_1016_j_rmed_2013_11_016 crossref_primary_10_1177_1753465816676048 crossref_primary_10_1298_ptr_R0012 crossref_primary_10_15446_revfacmed_v66n3_63970 crossref_primary_10_1016_j_rmr_2022_01_014 crossref_primary_10_1517_14728214_2015_1102886 crossref_primary_10_1183_16000617_0065_2019 crossref_primary_10_1080_17476348_2016_1227244 crossref_primary_10_1186_s12931_018_0884_y crossref_primary_10_1080_21679169_2019_1578826 crossref_primary_10_1183_23120541_00245_2018 crossref_primary_10_23736_S1973_9087_18_05093_1 crossref_primary_10_1183_23120541_00107_2020 crossref_primary_10_1183_16000617_0092_2023 crossref_primary_10_1586_17476348_2016_1121104 crossref_primary_10_5694_mja17_00799 crossref_primary_10_1097_HCR_0b013e31828db112 crossref_primary_10_1016_j_opresp_2021_100100 crossref_primary_10_3390_jcm10143153 crossref_primary_10_4103_ecdt_ecdt_66_22 crossref_primary_10_3390_healthcare11111593 crossref_primary_10_1016_j_pneumo_2013_12_004 crossref_primary_10_3233_IES_210123 crossref_primary_10_1183_20734735_006916 crossref_primary_10_3233_THC_240285 crossref_primary_10_1186_s12890_017_0476_5 crossref_primary_10_1016_j_arbr_2013_06_003 crossref_primary_10_1080_09593985_2023_2245878 crossref_primary_10_1097_HCR_0000000000000338 crossref_primary_10_12968_ijpn_2012_18_7_331 crossref_primary_10_2490_jjrmc_60_102 crossref_primary_10_1097_HCR_0b013e3182839293 crossref_primary_10_1177_14799731211046022 crossref_primary_10_57224_jhpr_1072917 crossref_primary_10_3390_life13020506 crossref_primary_10_1183_09059180_00005613 crossref_primary_10_1111_resp_13146 crossref_primary_10_1111_resp_12650 crossref_primary_10_1159_000370126 crossref_primary_10_1097_HCR_0000000000000083 crossref_primary_10_1177_09733698241310941 crossref_primary_10_1016_j_resmer_2022_100948 crossref_primary_10_1016_j_rmed_2020_106184 crossref_primary_10_1016_j_rmr_2013_09_007 crossref_primary_10_1183_23120541_00591_2023 crossref_primary_10_4187_respcare_02520 crossref_primary_10_3390_arm90050052 crossref_primary_10_1159_000354112 crossref_primary_10_1080_17476348_2020_1776118 crossref_primary_10_1159_000517030 crossref_primary_10_1093_qjmed_hcw105 crossref_primary_10_1111_imj_13078 crossref_primary_10_1513_AnnalsATS_201703_244FR crossref_primary_10_1093_fampra_cmw077 crossref_primary_10_1007_s10067_019_04717_9 crossref_primary_10_1016_j_ft_2014_12_001 crossref_primary_10_1080_21679169_2023_2287511 crossref_primary_10_15406_ipmrj_2017_02_00063 crossref_primary_10_4103_jalh_jalh_5_24 crossref_primary_10_1136_thoraxjnl_2016_208638 crossref_primary_10_1016_j_rmed_2014_03_008 crossref_primary_10_3390_ijerph18147643 crossref_primary_10_4081_mrm_2020_707 crossref_primary_10_1186_1471_2466_13_8 crossref_primary_10_2174_1389557523666230816090112 crossref_primary_10_1016_j_lpm_2023_104166 crossref_primary_10_3389_fmed_2022_917973 crossref_primary_10_1080_24745332_2018_1503456 crossref_primary_10_1177_1753465816686743 crossref_primary_10_1089_respcare_11712 crossref_primary_10_1097_MCP_0b013e3283541337 crossref_primary_10_1016_j_ccm_2014_02_016 crossref_primary_10_31189_2165_7629_9_2_67 crossref_primary_10_3390_jcm9051567 crossref_primary_10_1097_HCR_0000000000000315 crossref_primary_10_1111_resp_12649 crossref_primary_10_1007_s13665_012_0031_z crossref_primary_10_1016_j_ft_2022_01_001 crossref_primary_10_1097_HCR_0000000000000275 crossref_primary_10_4103_ejb_ejb_64_18 |
Cites_doi | 10.1016/j.rmed.2009.04.024 10.1164/rccm.200508-1211ST 10.1136/thx.2007.088070 10.1164/rccm.2009-040GL 10.1378/chest.09-0241 10.1002/14651858.CD006322.pub2 10.1164/rccm.200302-219OC 10.1037/0022-3514.51.6.1173 10.1002/14651858.CD003793.pub2 10.1016/j.rmed.2007.03.012 10.1183/09031936.93.01060510 10.1378/chest.06-1466 10.1378/chest.08-1458 10.1111/j.1440-1843.2007.01205.x 10.1164/rccm.200604-488OC 10.1164/rccm.2111053 10.1148/radiol.2321030392 10.1016/j.rmed.2008.08.014 10.1097/00063198-199809000-00006 10.1111/j.1440-1843.2011.02029.x 10.1136/thx.43.9.708 10.1378/chest.116.5.1175 10.1183/09031936.04.00137203 10.1164/ajrccm.166.1.at1102 10.1136/oem.60.3.201 10.1136/thx.2008.101691 10.1016/0197-2456(89)90005-6 10.1164/ajrccm.161.2.ats3-00 10.1159/000315475 |
ContentType | Journal Article |
Copyright | 2011 Elsevier Ltd Elsevier Ltd 2015 INIST-CNRS Copyright © 2011 Elsevier Ltd. All rights reserved. |
Copyright_xml | – notice: 2011 Elsevier Ltd – notice: Elsevier Ltd – notice: 2015 INIST-CNRS – notice: Copyright © 2011 Elsevier Ltd. All rights reserved. |
DBID | 6I. AAFTH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7U9 ASE FPQ H94 K6X K9. M7N NAPCQ 7X8 |
DOI | 10.1016/j.rmed.2011.11.014 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Virology and AIDS Abstracts British Nursing Index British Nursing Index (BNI) (1985 to Present) AIDS and Cancer Research Abstracts British Nursing Index ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium British Nursing Index Virology and AIDS Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic British Nursing Index AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-3064 |
EndPage | 435 |
ExternalDocumentID | 2745518681 22182340 25572644 10_1016_j_rmed_2011_11_014 S0954611111004355 1_s2_0_S0954611111004355 |
Genre | Evaluation Studies Journal Article |
GeographicLocations | Australia |
GeographicLocations_xml | – name: Australia |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29P 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABMAC ABMZM ABOCM ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AFFNX AFJKZ AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI ASPBG AVWKF AXJTR AZFZN BKEYQ BKOJK BLXMC BNPGV BNQBC BPHCQ BVXVI CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HEJ HMK HMO HVGLF HZ~ IHE IXB J1W K-O KOM L7B M29 M41 MO0 N9A O-L O9- OAUVE OI- OK1 OU. OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 R2- ROL RPZ RSU SAE SDF SDG SEL SES SEW SPCBC SSH SSZ SV3 T5K UHS UV1 WH7 WOW WUQ X7M Z5R ZGI ZXP ~G- 0SF 3V. 6I. 7RV 7X7 AACTN AAFTH ABVKL AFCTW AFKRA AFKWA AJOXV AMFUW BENPR M0T M2O NCXOZ RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 AAYXX CITATION AGRNS IQODW CGR CUY CVF ECM EIF NPM 7U9 ASE FPQ H94 K6X K9. M7N NAPCQ 7X8 |
ID | FETCH-LOGICAL-c695t-25be1bc2852f0e1779c6e944e16ee1c3d8387088e776fce36ded2670a56dc6233 |
IEDL.DBID | IXB |
ISSN | 0954-6111 1532-3064 |
IngestDate | Thu Sep 04 21:03:24 EDT 2025 Fri Sep 05 09:23:00 EDT 2025 Thu Sep 04 17:59:01 EDT 2025 Sat Aug 23 12:35:30 EDT 2025 Thu Apr 03 06:58:23 EDT 2025 Mon Jul 21 09:16:24 EDT 2025 Sun Aug 31 07:19:50 EDT 2025 Thu Apr 24 22:51:35 EDT 2025 Fri Feb 23 02:31:39 EST 2024 Sun Feb 23 10:19:34 EST 2025 Tue Aug 26 19:58:24 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | ILD SpO 2 CRQ Lung diseases ROC RVSP MID Dyspnoea FVC Pulmonary fibrosis Exercise DLCO Interstitial 6MWD IPF forced vital capacity right ventricular systolic pressure interstitial lung disease oxyhaemoglobin saturation measured by pulse oximetry receiver operating characteristic idiopathic pulmonary fibrosis 6-minute walk distance diffusing capacity for carbon monoxide minimal important difference Chronic Respiratory Questionnaire Physical exercise Lung disease Respiratory disease Interstitial pneumonitis Rehabilitation Predictive factor Pneumology |
Language | English |
License | http://www.elsevier.com/open-access/userlicense/1.0 https://www.elsevier.com/tdm/userlicense/1.0 https://www.elsevier.com/open-access/userlicense/1.0 CC BY 4.0 Copyright © 2011 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c695t-25be1bc2852f0e1779c6e944e16ee1c3d8387088e776fce36ded2670a56dc6233 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Undefined-1 ObjectType-Feature-3 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0954611111004355 |
PMID | 22182340 |
PQID | 1035137652 |
PQPubID | 1216389 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_916696700 proquest_miscellaneous_1095452227 proquest_miscellaneous_1027985717 proquest_journals_1035137652 pubmed_primary_22182340 pascalfrancis_primary_25572644 crossref_citationtrail_10_1016_j_rmed_2011_11_014 crossref_primary_10_1016_j_rmed_2011_11_014 elsevier_sciencedirect_doi_10_1016_j_rmed_2011_11_014 elsevier_clinicalkeyesjournals_1_s2_0_S0954611111004355 elsevier_clinicalkey_doi_10_1016_j_rmed_2011_11_014 |
PublicationCentury | 2000 |
PublicationDate | 2012-03-01 |
PublicationDateYYYYMMDD | 2012-03-01 |
PublicationDate_xml | – month: 03 year: 2012 text: 2012-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Kidlington |
PublicationPlace_xml | – name: Kidlington – name: England – name: Oxford |
PublicationTitle | Respiratory medicine |
PublicationTitleAlternate | Respir Med |
PublicationYear | 2012 |
Publisher | Elsevier Ltd Elsevier Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier – name: Elsevier Limited |
References | Lee, Singh, Pang, de Klerk, Hillman, Musk (bib7) 2003; 60 Wells, Desai, Rubens, Goh, Cramer, Nicholson, Colby, du Bois, Hansell (bib18) 2003; 167 Holland, Hill (bib5) 2008 Hamada, Nagai, Tanaka, Handa, Shigematsu, Nagao, Mishima, Kitaichi, Izumi (bib19) 2007; 131 Markos, Musk, Finucane (bib6) 1988; 43 Bradley, Branley, Egan, Greaves, Hansell, Harrison, Hirani, Hubbard, Lake, Millar, Wallace, Wells, Whyte, Wilsher (bib30) 2008; 63 Holland, Hill, Conron, Munro, McDonald (bib1) 2008; 63 Nici, Donner, Wouters, Zuwallack, Ambrosino, Bourbeau, Carone, Celli, Engelen, Fahy, Garvey, Goldstein, Gosselink, Lareau, MacIntyre, Maltais, Morgan, O’Donnell, Prefault, Reardon, Rochester, Schols, Singh, Troosters (bib29) 2006; 173 Hallstrand, Boitano, Johnson, Spada, Hayes, Raghu (bib15) 2005; 25 Lacasse, Goldstein, Lasserson, Martin (bib3) 2006 Swigris, Brown, Make, Wamboldt (bib10) 2008; 102 Jaeschke, Singer, Guyatt (bib17) 1989; 10 Baron, Kenny (bib27) 1986; 51 Sette, Neder, Nery, Kavakama, Rodrigues, Terra-Filho, Guimaraes, Bagatin, Muller (bib8) 2004; 232 Flaherty, Andrei, Murray, Fraley, Colby, Travis, Lama, Kazerooni, Gross, Toews, Martinez (bib20) 2006; 174 Lama, Flaherty, Toews, Colby, Travis, Long, Murray, Kazerooni, Gross, Lynch, Martinez (bib26) 2003; 168 Ferreira, Garvey, Connors, Hilling, Rigler, Farrell, Cayou, Shariat, Collard (bib21) 2009; 135 Bradley, Branley, Egan, Greaves, Hansell, Harrison, Hirani, Hubbard, Lake, Millar, Wallace, Wells, Whyte, Wilsher (bib9) 2008; 63 Idiopathic Pulmonary Fibrosis (bib12) 2000; 161 Chang, Curtis, Patrick, Raghu (bib16) 1999; 116 Collard, Loyd, King, Lancaster (bib4) 2007; 101 Holland, Hill, Conron, Munro, McDonald (bib13) 2009; 103 Kozu, Jenkins, Senjyu (bib24) 2011; 16 Kozu, Senjyu, Jenkins, Mukae, Sakamoto, Kohno (bib22) 2011; 81 Raghu, Collard, Egan, Martinez, Behr, Brown, Colby, Cordier, Flaherty, Lasky, Lynch, Ryu, Swigris, Wells, Ancochea, Bouros, Carvalho, Costabel, Ebina, Hansell, Johkoh, Kim, King, Kondoh, Myers, Muller, Nicholson, Richeldi, Selman, Dudden, Griss, Protzko, Schunemann (bib25) 2011; 183 Markovitz, Cooper (bib11) 1998; 4 Salhi, Troosters, Behaegel, Joos, Derom (bib23) 2010; 137 Nishiyama, Kondoh, Kimura, Kato, Kataoka, Ogawa, Watanabe, Arizono, Nishimura, Taniguchi (bib2) 2008; 13 (bib14) 2002; 166 Agusti, Roca, Rodriguez-Roisin, Xaubet, Agusti-Vidal (bib28) 1988; 1 Hallstrand (10.1016/j.rmed.2011.11.014_bib15) 2005; 25 Lacasse (10.1016/j.rmed.2011.11.014_bib3) 2006 Hamada (10.1016/j.rmed.2011.11.014_bib19) 2007; 131 Collard (10.1016/j.rmed.2011.11.014_bib4) 2007; 101 Idiopathic Pulmonary Fibrosis (10.1016/j.rmed.2011.11.014_bib12) 2000; 161 Ferreira (10.1016/j.rmed.2011.11.014_bib21) 2009; 135 Kozu (10.1016/j.rmed.2011.11.014_bib24) 2011; 16 Swigris (10.1016/j.rmed.2011.11.014_bib10) 2008; 102 Lama (10.1016/j.rmed.2011.11.014_bib26) 2003; 168 Wells (10.1016/j.rmed.2011.11.014_bib18) 2003; 167 Agusti (10.1016/j.rmed.2011.11.014_bib28) 1988; 1 Kozu (10.1016/j.rmed.2011.11.014_bib22) 2011; 81 Markovitz (10.1016/j.rmed.2011.11.014_bib11) 1998; 4 Nishiyama (10.1016/j.rmed.2011.11.014_bib2) 2008; 13 Bradley (10.1016/j.rmed.2011.11.014_bib9) 2008; 63 Chang (10.1016/j.rmed.2011.11.014_bib16) 1999; 116 Baron (10.1016/j.rmed.2011.11.014_bib27) 1986; 51 Holland (10.1016/j.rmed.2011.11.014_bib5) 2008 Markos (10.1016/j.rmed.2011.11.014_bib6) 1988; 43 Jaeschke (10.1016/j.rmed.2011.11.014_bib17) 1989; 10 Sette (10.1016/j.rmed.2011.11.014_bib8) 2004; 232 Nici (10.1016/j.rmed.2011.11.014_bib29) 2006; 173 Lee (10.1016/j.rmed.2011.11.014_bib7) 2003; 60 Bradley (10.1016/j.rmed.2011.11.014_bib30) 2008; 63 (10.1016/j.rmed.2011.11.014_bib14) 2002; 166 Holland (10.1016/j.rmed.2011.11.014_bib1) 2008; 63 Raghu (10.1016/j.rmed.2011.11.014_bib25) 2011; 183 Holland (10.1016/j.rmed.2011.11.014_bib13) 2009; 103 Salhi (10.1016/j.rmed.2011.11.014_bib23) 2010; 137 Flaherty (10.1016/j.rmed.2011.11.014_bib20) 2006; 174 |
References_xml | – volume: 13 start-page: 394 year: 2008 end-page: 399 ident: bib2 article-title: Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis publication-title: Respirology – volume: 63 start-page: v1 year: 2008 end-page: 58 ident: bib30 article-title: Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society publication-title: Thorax – volume: 161 start-page: 646 year: 2000 end-page: 664 ident: bib12 article-title: Diagnosis and treatment. International consensus statement publication-title: Am J Respir Crit Care Med – volume: 168 start-page: 1084 year: 2003 end-page: 1090 ident: bib26 article-title: Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia publication-title: Am J Respir Crit Care Med – volume: 166 start-page: 111 year: 2002 end-page: 117 ident: bib14 article-title: ATS statement: guidelines for the six-minute walk test publication-title: Am J Respir Crit Care Med – volume: 25 start-page: 96 year: 2005 end-page: 103 ident: bib15 article-title: The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis publication-title: Eur Respir J – volume: 137 start-page: 273 year: 2010 end-page: 279 ident: bib23 article-title: Effects of pulmonary rehabilitation in patients with restrictive lung diseases publication-title: Chest – volume: 174 start-page: 803 year: 2006 end-page: 809 ident: bib20 article-title: Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test publication-title: Am J Respir Crit Care Med – volume: 135 start-page: 442 year: 2009 end-page: 447 ident: bib21 article-title: Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response publication-title: Chest – volume: 101 start-page: 2011 year: 2007 end-page: 2016 ident: bib4 article-title: Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians publication-title: Respir Med – volume: 167 start-page: 962 year: 2003 end-page: 969 ident: bib18 article-title: Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography publication-title: Am J Respir Crit Care Med – volume: 173 start-page: 1390 year: 2006 end-page: 1413 ident: bib29 article-title: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation publication-title: Am J Respir Crit Care Med – volume: 63 start-page: v1 year: 2008 end-page: 58 ident: bib9 article-title: Interstitial lung disease guideline publication-title: Thorax – year: 2008 ident: bib5 article-title: Physical training for interstitial lung disease publication-title: Cochrane Database Syst Rev – volume: 131 start-page: 650 year: 2007 end-page: 656 ident: bib19 article-title: Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis publication-title: Chest – volume: 116 start-page: 1175 year: 1999 end-page: 1182 ident: bib16 article-title: Assessment of health-related quality of life in patients with interstitial lung disease publication-title: Chest – volume: 63 start-page: 549 year: 2008 end-page: 554 ident: bib1 article-title: Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease publication-title: Thorax – volume: 183 start-page: 788 year: 2011 end-page: 824 ident: bib25 article-title: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management publication-title: Am J Respir Crit Care Med – year: 2006 ident: bib3 article-title: Pulmonary rehabilitation for chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev – volume: 60 start-page: 201 year: 2003 end-page: 206 ident: bib7 article-title: Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis publication-title: Occup Environ Med – volume: 232 start-page: 66 year: 2004 end-page: 74 ident: bib8 article-title: Thin-section CT abnormalities and pulmonary gas exchange impairment in workers exposed to asbestos publication-title: Radiology – volume: 4 start-page: 272 year: 1998 end-page: 280 ident: bib11 article-title: Exercise and interstitial lung disease publication-title: Curr Opin Pulm Med – volume: 102 start-page: 1675 year: 2008 end-page: 1680 ident: bib10 article-title: Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation publication-title: Respir Med – volume: 103 start-page: 1430 year: 2009 end-page: 1435 ident: bib13 article-title: Small changes in six-minute walk distance are important in diffuse parenchymal lung disease publication-title: Respir Med – volume: 51 start-page: 1173 year: 1986 end-page: 1182 ident: bib27 article-title: The moderator–mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations publication-title: J Pers Soc Psychol – volume: 10 start-page: 407 year: 1989 end-page: 415 ident: bib17 article-title: Measurement of health status. Ascertaining the minimal clinically important difference publication-title: Control Clin Trials – volume: 43 start-page: 708 year: 1988 end-page: 714 ident: bib6 article-title: Functional similarities of asbestosis and cryptogenic fibrosing alveolitis publication-title: Thorax – volume: 1 start-page: 510 year: 1988 end-page: 516 ident: bib28 article-title: Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis publication-title: Eur Respir J – volume: 16 start-page: 1196 year: 2011 end-page: 1202 ident: bib24 article-title: Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis publication-title: Respirology – volume: 81 start-page: 196 year: 2011 end-page: 205 ident: bib22 article-title: Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease publication-title: Respiration – volume: 103 start-page: 1430 year: 2009 ident: 10.1016/j.rmed.2011.11.014_bib13 article-title: Small changes in six-minute walk distance are important in diffuse parenchymal lung disease publication-title: Respir Med doi: 10.1016/j.rmed.2009.04.024 – volume: 173 start-page: 1390 year: 2006 ident: 10.1016/j.rmed.2011.11.014_bib29 article-title: American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200508-1211ST – volume: 63 start-page: 549 year: 2008 ident: 10.1016/j.rmed.2011.11.014_bib1 article-title: Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease publication-title: Thorax doi: 10.1136/thx.2007.088070 – volume: 183 start-page: 788 year: 2011 ident: 10.1016/j.rmed.2011.11.014_bib25 article-title: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.2009-040GL – volume: 137 start-page: 273 year: 2010 ident: 10.1016/j.rmed.2011.11.014_bib23 article-title: Effects of pulmonary rehabilitation in patients with restrictive lung diseases publication-title: Chest doi: 10.1378/chest.09-0241 – year: 2008 ident: 10.1016/j.rmed.2011.11.014_bib5 article-title: Physical training for interstitial lung disease publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD006322.pub2 – volume: 168 start-page: 1084 year: 2003 ident: 10.1016/j.rmed.2011.11.014_bib26 article-title: Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200302-219OC – volume: 51 start-page: 1173 year: 1986 ident: 10.1016/j.rmed.2011.11.014_bib27 article-title: The moderator–mediator variable distinction in social psychological research: conceptual, strategic and statistical considerations publication-title: J Pers Soc Psychol doi: 10.1037/0022-3514.51.6.1173 – year: 2006 ident: 10.1016/j.rmed.2011.11.014_bib3 article-title: Pulmonary rehabilitation for chronic obstructive pulmonary disease publication-title: Cochrane Database Syst Rev doi: 10.1002/14651858.CD003793.pub2 – volume: 101 start-page: 2011 year: 2007 ident: 10.1016/j.rmed.2011.11.014_bib4 article-title: Current diagnosis and management of idiopathic pulmonary fibrosis: a survey of academic physicians publication-title: Respir Med doi: 10.1016/j.rmed.2007.03.012 – volume: 1 start-page: 510 year: 1988 ident: 10.1016/j.rmed.2011.11.014_bib28 article-title: Different patterns of gas exchange response to exercise in asbestosis and idiopathic pulmonary fibrosis publication-title: Eur Respir J doi: 10.1183/09031936.93.01060510 – volume: 131 start-page: 650 year: 2007 ident: 10.1016/j.rmed.2011.11.014_bib19 article-title: Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis publication-title: Chest doi: 10.1378/chest.06-1466 – volume: 135 start-page: 442 year: 2009 ident: 10.1016/j.rmed.2011.11.014_bib21 article-title: Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response publication-title: Chest doi: 10.1378/chest.08-1458 – volume: 13 start-page: 394 year: 2008 ident: 10.1016/j.rmed.2011.11.014_bib2 article-title: Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis publication-title: Respirology doi: 10.1111/j.1440-1843.2007.01205.x – volume: 174 start-page: 803 year: 2006 ident: 10.1016/j.rmed.2011.11.014_bib20 article-title: Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200604-488OC – volume: 167 start-page: 962 year: 2003 ident: 10.1016/j.rmed.2011.11.014_bib18 article-title: Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.2111053 – volume: 63 start-page: v1 issue: Suppl. 5 year: 2008 ident: 10.1016/j.rmed.2011.11.014_bib30 article-title: Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society publication-title: Thorax – volume: 232 start-page: 66 year: 2004 ident: 10.1016/j.rmed.2011.11.014_bib8 article-title: Thin-section CT abnormalities and pulmonary gas exchange impairment in workers exposed to asbestos publication-title: Radiology doi: 10.1148/radiol.2321030392 – volume: 102 start-page: 1675 year: 2008 ident: 10.1016/j.rmed.2011.11.014_bib10 article-title: Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation publication-title: Respir Med doi: 10.1016/j.rmed.2008.08.014 – volume: 4 start-page: 272 year: 1998 ident: 10.1016/j.rmed.2011.11.014_bib11 article-title: Exercise and interstitial lung disease publication-title: Curr Opin Pulm Med doi: 10.1097/00063198-199809000-00006 – volume: 16 start-page: 1196 year: 2011 ident: 10.1016/j.rmed.2011.11.014_bib24 article-title: Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis publication-title: Respirology doi: 10.1111/j.1440-1843.2011.02029.x – volume: 43 start-page: 708 year: 1988 ident: 10.1016/j.rmed.2011.11.014_bib6 article-title: Functional similarities of asbestosis and cryptogenic fibrosing alveolitis publication-title: Thorax doi: 10.1136/thx.43.9.708 – volume: 116 start-page: 1175 year: 1999 ident: 10.1016/j.rmed.2011.11.014_bib16 article-title: Assessment of health-related quality of life in patients with interstitial lung disease publication-title: Chest doi: 10.1378/chest.116.5.1175 – volume: 25 start-page: 96 year: 2005 ident: 10.1016/j.rmed.2011.11.014_bib15 article-title: The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis publication-title: Eur Respir J doi: 10.1183/09031936.04.00137203 – volume: 166 start-page: 111 year: 2002 ident: 10.1016/j.rmed.2011.11.014_bib14 article-title: ATS statement: guidelines for the six-minute walk test publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.166.1.at1102 – volume: 60 start-page: 201 year: 2003 ident: 10.1016/j.rmed.2011.11.014_bib7 article-title: Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis publication-title: Occup Environ Med doi: 10.1136/oem.60.3.201 – volume: 63 start-page: v1 year: 2008 ident: 10.1016/j.rmed.2011.11.014_bib9 article-title: Interstitial lung disease guideline publication-title: Thorax doi: 10.1136/thx.2008.101691 – volume: 10 start-page: 407 year: 1989 ident: 10.1016/j.rmed.2011.11.014_bib17 article-title: Measurement of health status. Ascertaining the minimal clinically important difference publication-title: Control Clin Trials doi: 10.1016/0197-2456(89)90005-6 – volume: 161 start-page: 646 year: 2000 ident: 10.1016/j.rmed.2011.11.014_bib12 article-title: Diagnosis and treatment. International consensus statement publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.161.2.ats3-00 – volume: 81 start-page: 196 year: 2011 ident: 10.1016/j.rmed.2011.11.014_bib22 article-title: Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease publication-title: Respiration doi: 10.1159/000315475 |
SSID | ssj0009440 |
Score | 2.364279 |
Snippet | Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked variation in outcomes... Summary Background Pulmonary rehabilitation improves functional capacity and symptoms in the interstitial lung diseases (ILDs), however there is marked... |
SourceID | proquest pubmed pascalfrancis crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 429 |
SubjectTerms | Aged Biological and medical sciences Clinical trials Diet Disease Dyspnea - etiology Dyspnea - physiopathology Dyspnea - rehabilitation Dyspnoea Exercise Exercise Test - methods Follow-Up Studies Humans Idiopathic Pulmonary Fibrosis - physiopathology Idiopathic Pulmonary Fibrosis - rehabilitation Interstitial Lung diseases Lung Diseases, Interstitial - etiology Lung Diseases, Interstitial - physiopathology Lung Diseases, Interstitial - rehabilitation Medical sciences Middle Aged Miscellaneous Noncitizens Oxygen - blood Oxyhemoglobins - metabolism Partial Pressure Pneumology Prognosis Pulmonary fibrosis Pulmonary/Respiratory Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Respiratory system : syndromes and miscellaneous diseases Severity of Illness Index Treatment Outcome Vital Capacity - physiology Walking - physiology |
Title | Predictors of benefit following pulmonary rehabilitation for interstitial lung disease |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0954611111004355 https://www.clinicalkey.es/playcontent/1-s2.0-S0954611111004355 https://dx.doi.org/10.1016/j.rmed.2011.11.014 https://www.ncbi.nlm.nih.gov/pubmed/22182340 https://www.proquest.com/docview/1035137652 https://www.proquest.com/docview/1027985717 https://www.proquest.com/docview/1095452227 https://www.proquest.com/docview/916696700 |
Volume | 106 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEB_OE0Q4xO-L3pUVfJPY7GY_ksfz8KiKh6AnfVuSzQYqpS1pi_ji3-5Msmkp2h74lo_ZZDOZ-c0sOx8ArxNRlFmeVLF0qG7SexkXKqWM5VTWeVVx79poi2s9upEfx2p8BJd9LgyFVQbs7zC9RetwZRi4OVxMJsOv6BxITRpPRc_QbCIOU1YpJfGN320L78o2KZKIY6IOiTNdjFeDFqcr40mVPLncZ5xOFsUSWVZ3vS72O6OtUbp6CA-CN8kuugk_giM_ewz3Pof98ifw_UtDx9RRh81rViKw1ZMVq_Hnz3-i0WKL9RTlsGh-sWanZDeSNIxKSTQUS4AyyqaICixs5zyFm6v33y5HceikEDudq1UsVOl56USmRJ14bkzutEfOeK695y6tshT1Nsu8Mbp2PtWVr4Q2SaF05dBBSp_B8Ww-86fAMqo5JlNTIGLLkhd5oURpanyOyzwiRgS8Z6F1Yc7U7WJq-3iyH5bYbontuP6wyPYI3mzGLLoiGwep0_7P2D59FAHPog04OMr8a5RfBp1dWm6Xwib2L7mKQG1G7ojmrW8c7IjN5tNwFWfID43grJcju50Fbe0i6isRwavNbdR52sgpZn6-Jhph8kzhSvwQTU7t44VAGraHBpcGOqc8rQied2K8nSNV9k9l8uI_P_4l3Mcz0UXrncHxqln7c3TfVuUA7rz9zQdw9-LDp9H1oNXWP2knRAM |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9NAEB_OE1QQ8fui57mCbxKa3exH8qiHR0_vDsE76duSbDZQKW1JWw7_e2eSTUvRVvAtJLPJ7mS-lp35DcD7RBRllidVLB2qm_RexoVKqWI5lXVeVdy7NtviSg9v5JeRGh3AaV8LQ2mVwfZ3Nr211uHOIHBzMB-PB98xOJCaNJ5Az9Bt3oG7GA1oAtA_H33aIO_KtiqSqGMiD5UzXZJXgy6nw_EkKE8ud3mnh_NigTyru2YXu6PR1iudPYZHIZxkH7sZP4EDP30K9y7Dgfkz-PGtoWtqqcNmNSvRstXjJavx789u0Wux-WqCglg0v1izhdmNJA0jLImGkglQSNkEzQIL5znP4ebs8_XpMA6tFGKnc7WMhSo9L53IlKgTz43JnfbIGc-199ylVZai4maZN0bXzqe68pXQJimUrhxGSOkLOJzOpv4IWEagYzI1BZpsWfIiL5QoTY3vcZlHkxEB71loXZgztbuY2D6h7KcltltiO25ALLI9gg_rMfMOZWMvddr_GdvXj6LFs-gE9o4yfxvlF0FpF5bbhbCJ_UOwIlDrkVuy-c8vnmyJzXppuI0zFIhGcNzLkd3Mgs520ewrEcG79WNUejrJKaZ-tiIaYfJM4VZ8H01O_eOFQBq2gwb3BjqnQq0IXnZivJkjQfunMnn1n4t_C_eH15cX9uL86utreIBPRJe6dwyHy2bl32AstyxPWl39DfDWRJs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Predictors+of+benefit+following+pulmonary+rehabilitation+for+interstitial+lung+disease&rft.jtitle=Respiratory+medicine&rft.au=Holland%2C+Anne+E.&rft.au=Hill%2C+Catherine+J.&rft.au=Glaspole%2C+Ian&rft.au=Goh%2C+Nicole&rft.date=2012-03-01&rft.issn=0954-6111&rft.volume=106&rft.issue=3&rft.spage=429&rft.epage=435&rft_id=info:doi/10.1016%2Fj.rmed.2011.11.014&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_rmed_2011_11_014 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09546111%2FS0954611112X00027%2Fcov150h.gif |